Health
AstraZeneca's Breast Cancer Drug Fails Key Trial, Narrowing Treatment Options
By Editor • September 12, 2026 • 1 min read
AstraZeneca's camizestrant fails a key trial for advanced breast cancer, limiting its treatment options despite recent U.S. approval.
Read more